, Tracking Stock Market Picks
Enter Symbol:

down 55.90 %


Posted on: Monday,  Dec 17, 2007  8:25 AM ET by CIBC Wrld Mkts

CIBC Wrld Mkts rated Buy BIOFORM MEDICAL INC (NASDAQ: BFRM) on 12/17/2007, when the stock price was $7.71.
Since then, BIOFORM MEDICAL INC has lost 55.90% as of 02/19/2010's recent price of $3.40.
If you would have followed this CIBC Wrld Mkts's recommendation on BFRM, you would have lost 55.9% of your investment in 795 days.

BioForm Medical, Inc. (BioForm) is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient?s appearance. The Company?s product is RADIESSE, an injectable dermal filler designed to provide aesthetic improvement for patients. RADIESSE provides initial aesthetic correction and approximately 12 months? duration of aesthetic improvement in many patients. The Company has shipped over 1,000,000 syringes worldwide. It has obtained licenses to or acquired three products: Polidocanol, a sclerotherapy treatment in Europe for varicose veins sold under the trade name Aethoxysklerol; BIOGLUE AESTHETIC medical adhesive, a Class III medical device in clinical testing for tissue fixation in browplasty, or forehead lift, and RELAXED EXPRESSIONS System, a radiofrequency 510(k) medical device cleared by the United States Food and Drug Administration (FDA), for use in creating radiofrequency (RF) heat lesions in nerve tissue.

CIBC World Markets strives to deliver leading edge investment research to investing clients through our multi-faceted, firm-wide research product offering. Our research has consistently been recognized as a top research source for its breadth of coverage, industry knowledge and quality of work in generating profitable and timely investment ideas. We provide in-depth coverage for all of the major sectors of the Canadian economy and select coverage of U.S. companies. Our analytical teams remain committed to identifying trends early and developing exploitable investment opportunities across the market capitalization spectrum. With the continued growth in quantitative and computerized investing strategies, we have also developed leading edge quantitative and technical research products to partner with our fundamental approach. Our products are available through several automated avenues: email, website, and third-party market vendors. Client service is our driving force and we constantly advance in offering greater product customization options.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2007 8:25 AM Buy
7.71 12.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  14.52 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy